Characterization of 1-hydroxypyrene as a novel marker substrate of 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase(s)

Pharmacology and Toxicology

Volumn 80, Issue 3, 1997, Pages 152-158

  Luukkanen, Leena ^a   Elovaara, Eivor ^b   Lautala, Pia ^a   Taskinen, Jyrki ^a   Vainio, Harri ^c  

^a Division of Pharmaceutical Chemistry   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXYPYRENE; 3 METHYLCHOLANTHRENE; 4,4' METHYLENEBIS(2 CHLOROANILINE); ACETONE; AROCLOR 1254; CREOSOTE; DRUG METABOLITE; GLUCURONOSYLTRANSFERASE; PHENOBARBITAL; POLYCHLORINATED BIPHENYL; PYRAZOLE; PYRENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME KINETICS; FLUOROMETRY; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030895678     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb00389.x     Document Type: Article

References (39)

1. Antoine, B., J. Magdalou & G. Siest: Kinetic properties of UDP-glucuronosyltransferase(s) in different membranes of rat liver cells. Xenobiotica 1984, 14, 575-579.
2. Antoine, B., J. A. Boutin & G. Siest: Heterogeneity of hepatic UDP-glucuronosyltransferase activities. Investigations of isoenzymes involved in p-nitrophenol glucuronidation. Comp. Biochem. Physiol. 1993, 106, 241-248.
3. Bock, K. W., W. Fröhling, H. Remmer & B. Rexer: Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim. Biophys. Acta 1973, 327, 46-56.
4. Bock, K. W., B. S. Bock-Hennig, G. Fischer, W. Lilienblum & G. Schirmer: UDP-glucuronyltransferases and their toxicological significance. Adv. Exp. Med. Biol. 1986, 197 (Biol. React. Intermed. III), 171-184.
5. Bock, K., H. Gschaidmeier, A. Seidel, S. Baird & B. Burchell: Mono- and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholantrene inducible phenol UDP-glucuronosyltransferases (UGT1A1). Mol. Pharmacol. 1992, 42, 613-618.
6. Boutin, J. A., J. Thomassin, G. Siest & A. Cartier: Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase activities. Biochem. Pharmacol. 1985, 34, 2235-2249.
7. Burchell, B., D. Nebert, D. Nelson, K. Bock, T. Iyanagi, P. Jansen, D. Lancet, G. Mulder, J. Roy Chowdhury, G. Siest, T. Tephly & P. Mackenzie: The UDP glucuronosyltransferase gene superfamily: Suggested nomenclature based on evolutionary divergence. DNA Cell Biol. 1991, 10, 487-494.
8. Cocker, J., A. R. Boobis, H. K. Wilson & D. Gompertz: Evidence that a β-N-glucuronide of 4,4′-methylenebis (2-chloroaniline) (MbOCA) is a major urinary metabolite in man: implications for biological monitoring. Brit. J. Ind. Med. 1990, 47, 154-161.
9. Di Cera, E.: Use of weighting functions in data fitting. Meth. Enzymol. 1992, 210, 68-87.
10. Ebner, T. & B. Burchell: Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug. Metab. Dispos. 1993, 21, 50-55.
11. Elovaara, E., P. Heikkilä, L. Pyy, P. Mutanen & V Riihimäki: Significance of dermal and respiratory uptake in creosote workers: exposure to polycyclic aromatic hydrocarbons and urinary excretion of 1-hydroxypyrene. Occup. Environ. Med. 1995, 52, 196-203.
12. Elovaara, E., E. Hietanen, C. Jansen & H. Vainio: Polycyclic aromatic hydrocarbon exposure monitoring by 1-hydroxypyrene in urine of psoriasis patients undergoing coal tar treatment. 48th Annual meeting of Finnish Pharmacological Society: New aspects of inflammation and anti-inflammatory drugs. Transmitteri 1996, 2, 16 (abstract).
13. Elovaara, E., L. Luukkanen, A. Hesso & H. Vainio: 1-Pyrenol and its glucuronide as urinary biomarkers of PAH exposure. In: International symposium on biological monitoring in occupational and environmental health 11.-13. Sept. 1996, Espoo, Finland, abstracts, pp. 179-180.
14. Falany, C. N. & T. R. Tephly: Separation, purification and characterization of three isoenzymes of UDP-glucuronosyltransferase from rat liver microsomes. Arch. Biochem. Biophys. 1983, 227, 248-258.
15. Gardiner, K., K. A. Hale, I. A. Calvert, C. Rice & J. M. Harrington: The suitability of the urinary metabolite 1-hydroxypyrene as an index of polynuclear aromatic hydrocarbon bioavailability from workers exposed to carbon black. Ann. Occup. Hyg. 1992, 36, 681-688.
16. Gschaidmeier, H., A. Seidel, B. Burchell & K. W. Bock: Formation of mono- and diglucuronides and other glycosides of benzo(a)pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem. Pharmacol. 1995, 49, 1601-1606.
17. Harding, D., S. Fournel-Giglieux, M. R. Jackson & B. Burchell: Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc. Natl. Acad. Sci. 1988, 85, 8381-8385.
18. Hänninen, O.: On the metabolic regulation in the glucuronic acid pathway in the rat tissues. Ann. Acad. Sci. Fenn. Ser. A II, 1968, 142, 1-96.
19. IARC International Agency for Research on Cancer: Overall evaluations of carcinogenicity: an updating of IARC Monographs Vols 1 to 42. IARC Monogr. Eval. Carcinog. Risks Chem. Hum. 1987, Suppl 7.
20. IARC International Agency for Research on Cancer, 4,4′-Methylenebis-(2-chloroaniline) (MOCA). In: IARC Monogr. Eval. Carcinog. Risks. Hum. 1993, 57, 271-303.
21. Irshaid, Y. M. & T. R. Tephly: Isolation and purification of two human liver UDP-glucuronosyltransferases. Mol. Pharmacol. 1987, 31, 27-34.
22. Iyanagi, T., M. Haniu, K. Sogawa, Y. Fujii-Kuriyama, S. Watanabe, J. E. Shively & K. F. Anan: Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. J. Biol. Chem. 1986, 261, 15607-15614.
23. Iyanagi, T.: Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat). J. Biol. Chem. 1991, 266, 24048-24052.
24. Jackson, M., S. Fournel-Giglieux, D. Harding & B. Burchell: Examination of the substrate specificity of cloned rat kidney phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Mol. Pharmacol. 1988, 34, 638-642.
25. Jin, C. J., J. O. Miners, B. Burchell & P. I. Mackenzie: The glucuronidation of hydroxylated metabolites of benzo(a)pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis 1993, 14, 2637-2639.
26. Jongeneelen, F. J.: Biological monitoring of environmental exposure to polycyclic aromatic hydrocarbons; 1-hydroxypyrene in urine of people. Toxicol. Lett. 1994, 72, 205-211.
27. Lilienblum, W., A. K. Walli & K. W. Bock: Differential induction of rat liver microsomal UDP-glucuronosyltransferase activities by various inducing agents. Biochem. Pharmacol. 1982, 31, 907-913.
28. Lowry, O., N. Rosebrough, L. Farr & R. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
29. Mackenzie, P.: Rat liver UDP-glucuronosyltransferase; sequence and expression of a cDNA encoding a phenobarbital inducible form. J. Biol Chem. 1986, 261, 6119-6125.
30. Mackenzie, P. I., L. Rodbourn & T. Iyanagi: Glucuronidation of carcinogen metabolites by complementary DNA-expressed uridine 5′-diphosphate glucuronosyltransferases. Cancer Res. 1993, 53, 1529-1533.
31. Maron, D. M. & B. N. Ames: Revised methods for the Salmonella mutagenicity test. Mut. Res. 1983, 113, 173-215.
32. Nylund, L., P. Heikkilä, M. Hämeilä, L. Pyy, K. Linnainmaa & M. Sorsa: Genotoxic effects and chemical compositions of four creosotes. Mutation Res. 1992, 265, 223-236.
33. Strickland, P. T., D. Kang, E. D. Bowman, A. Fitzwilliam, T. E. Downing, N. Rothman, J. D. Groopman & A. Weston: Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis. 1994, 15, 483-487.
34. Styczynski, P. M. Green, J. Puig, B. Coffman & T. Tephly: Purification and properties of a rat liver phenobarbital inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase. Mol. Pharmacol. 1991, 40, 80-84.
35. Vainio, H., E. Elovaara, L. Luukkanen, S. Anttila, I. Ulmanen, S. Fournel-Giglieux, M. Ouzzine, T. Pillot & J. Magdalou: Expression and co-induction of CYP1A1 and UGT1*6 in human lungs. Eur. J. Metabol. Pharmacokin. 1995, 20 (special issue), 47-48.
36. Vienneau, D. S., U. DeBoni & P. G. Wells: Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e-)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. Cancer Res. 1995, 55, 1045-1051.
37. Visser, T. J., A. Kaptein, H. van Toor, J. A. van Raaij, K. J. van den Berg, C. T. Joe, J. G. van Engelen & A. Brouwer: Glucuronidation of steroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions. Endocrinology. 1993, 133, 2177-2186
38. Wishart, G. J.: Demonstration of functional heterogeneity of hepatic uridine diphosphate glucuronosyltransferase activities after administration of 3-methylcholanthrene and phenobarbital to rats. Biochem. J. 1978, 174, 671-672.
39. Yokota, H. & A. Yuasa: Increase of a form of UDP-glucuronosyltransferase glucuronizing various phenolic xenobiotics and the corresponding translatable mRNA in 3-methylcholanthrene treated rat liver. J. Biochem. 1990, 107, 92-96.